VC  Allied Minds

http://www.alliedminds.com





     Office Locations:

100 High Street, 28th Floor
Boston, MA 02110
Phone: 617.419.1800
Fax: 617-419-1813

 

Stages:

  • Seed


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare

  •  

    Description:

    Allied Minds is a pre-seed investment company creating partnerships with key universities to fund corporate spin-offs resulting from successful early stage technology research. By providing corporate development support as well as finance, Allied Minds aims to guide early stage companies to commercial success. Allied Minds is capitalized and owned by international investors. It is not a manager of funds, and it earns its return on its ability to select and support worthwhile investments. The company invests in early stage opportunities based upon university research derived intellectual property (IP). The firm places no restrictions on the product, industry or service it will consider investing in. Allied is not sector specific and intends to build as diversified a portfolio as possible. However, all its investments will be early stage. Initially, Allied Mind's geographic investment focus will be the U.S., but depending on opportunities this could be expanded to a global network of partners and investments. To-date, they have raused more than $550M in capital, including $150M from its June 2014 IPO. Seed investments range from $250,000 to $1 million, and Series A investments from $5M to $10M.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Chris Silva CEO
    Donna See VP
    John Serafini Vice President
    Joseph Pignato CFO
    Marc Eichenberger Chief Operating Officer

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      07/26/2017


      Signature Medical


      MA


      $2,500,000


      Series A


     

    Portfolio companies include:


      Allied Bristol Life Sciences
        web link


      Allied Minds Federal Innovations
        web link


      Biotectix
        web link


      Bridge Sat Inc
        web link


      Cephalogics
        web link


      Cryoxtraxt
        web link


      Federated Wireless
        web link


      HawkEye 360
        web link


      LuxCath
        web link


      Novare Pharmaceuticals
        web link


      Optio Labs
        web link


      Optiolabs
        web link


      Percipient Networks


      Precision Biopsy
        web link


      RF Biosidics
        web link


      Seamless Devices
        web link


      Signature Medical


      Tinnitus Treatment Solutions
        web link


     

    Recent News: